Granholm, Anders http://orcid.org/0000-0001-5799-7655
Marker, Søren
Krag, Mette
Zampieri, Fernando G.
Thorsen-Meyer, Hans-Christian
Kaas-Hansen, Benjamin Skov
van der Horst, Iwan C. C.
Lange, Theis
Wetterslev, Jørn
Perner, Anders
Møller, Morten Hylander
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effects of pantoprazole vs. placebo on 1-year outcomes, resource use and employment status in ICU patients at risk for gastrointestinal bleeding: a secondary analysis of the SUP-ICU trial
https://doi.org/10.1007/s00134-022-06631-2
Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc analysis of the SUP-ICU trial
https://doi.org/10.1007/s00134-019-05903-8
Funding for this research was provided by:
Innovation Fund Denmark (4108-00011A)
Rigshospitalet
Capital Region of Denmark
Scandinavian Society of Anaesthesiology and Intensive Care Medicine
Ehrenreich’s Foundation
Aase and Ejnar Danielsens Foundation
Danish Society of Anaesthesiology and Intensive Care Medicine
Danish Medical Association
European Society of Intensive Care Medicine
Regions of Denmark
Article History
Received: 12 October 2019
Accepted: 16 December 2019
First Online: 14 January 2020
Compliance with ethical standards
:
: None. The Department of Intensive Care at Rigshospitalet receives support for other research projects from Ferring Pharmaceuticals, Denmark and the Novo Nordisk Foundation, Denmark. FGZ received grants for other research projects from Bactiguard, Sweden and from the Brazilian Ministry of Health, both unrelated to this work.